Variant report
Variant | nsv974619 |
---|---|
Chromosome Location | chr15:92824911-92831970 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr15:92828275-92828329 | LNCaP | prostate: | n/a | n/a |
2 | CTCF | chr15:92825280-92825430 | GM12864 | blood: | n/a | chr15:92825306-92825319 |
3 | POLR2A | chr15:92829198-92829349 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | POLR2A | chr15:92829179-92829358 | GM12878 | blood: | n/a | n/a |
5 | RAD21 | chr15:92828926-92829184 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLCO3A1-3 | chr15:92824714-92825314 | NONHSAT048517 |
No data |
No data |
Variant related genes | Relation type |
---|---|
NPM1P5 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11074058 | chr15:92824927-92824928 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs181072125 | chr15:92824935-92824936 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs569676709 | chr15:92824942-92824943 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs17599020 | chr15:92824974-92824975 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs549293186 | chr15:92825010-92825011 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs566016514 | chr15:92825015-92825016 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs537778608 | chr15:92825031-92825032 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs555770286 | chr15:92825048-92825049 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs373873982 | chr15:92825064-92825065 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs578011719 | chr15:92825098-92825099 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs537563774 | chr15:92825151-92825152 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs557027435 | chr15:92825153-92825154 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs573695901 | chr15:92825172-92825173 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs561495918 | chr15:92825177-92825178 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs186427417 | chr15:92825193-92825194 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs190383392 | chr15:92825241-92825242 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs376909702 | chr15:92825257-92825258 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs545245734 | chr15:92825259-92825260 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs565492487 | chr15:92825293-92825294 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs369188364 | chr15:92825313-92825314 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs112952323 | chr15:92825360-92825361 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs73533682 | chr15:92825370-92825371 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553104849 | chr15:92825402-92825403 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs563418260 | chr15:92825434-92825435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528883508 | chr15:92825444-92825445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549033634 | chr15:92825445-92825446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112036938 | chr15:92825454-92825455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534939102 | chr15:92825455-92825456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368990430 | chr15:92825478-92825479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182730801 | chr15:92825492-92825493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536895605 | chr15:92825493-92825494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139701282 | chr15:92825496-92825497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187365980 | chr15:92825511-92825512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536226989 | chr15:92825546-92825547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190672929 | chr15:92825551-92825552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577725166 | chr15:92825668-92825669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115490554 | chr15:92825675-92825676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370912413 | chr15:92825729-92825730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs117396314 | chr15:92825734-92825735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2387686 | chr15:92825832-92825833 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs377054900 | chr15:92825837-92825838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144603582 | chr15:92825852-92825853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544516991 | chr15:92825868-92825869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563353940 | chr15:92825870-92825871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529026390 | chr15:92825877-92825878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542616414 | chr15:92825896-92825897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184013819 | chr15:92825921-92825922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371528515 | chr15:92825933-92825934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557345665 | chr15:92825944-92825945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551650695 | chr15:92825972-92825973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Wilms tumour | 21544195 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Cancer | 16751803 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Epilepsy | 19486360 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Developmental delay | 21147756 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:92824200-92827200 | Weak transcription | Rectal Smooth Muscle | rectum |
2 | chr15:92824800-92825400 | Enhancers | Liver | Liver |
3 | chr15:92825400-92826800 | Weak transcription | Liver | Liver |
4 | chr15:92826800-92827600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
5 | chr15:92826800-92827800 | Enhancers | Liver | Liver |
6 | chr15:92826800-92827800 | Enhancers | Fetal Heart | heart |
7 | chr15:92827000-92827400 | Enhancers | Fetal Lung | lung |
8 | chr15:92827000-92827800 | Enhancers | Stomach Mucosa | stomach |
9 | chr15:92827200-92827600 | Enhancers | Rectal Smooth Muscle | rectum |
10 | chr15:92827800-92832400 | Weak transcription | Stomach Mucosa | stomach |
11 | chr15:92829400-92829800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |